Boehringer Ingelheim Makes Investment in RTW Georgia

Boehringer Ingelheim is expanding soon in Right to Work Athens, Georgia. In order to do this, the company is investing a total of $55 million toward the project. As a result, this will also create 55 new jobs. So this is great news!

From Area Development Magazine:

“Our new and expanded space has been specifically designed to encourage closer connections between teams and colleagues. After working in a distanced or virtual manner for so many months, we all have a much greater appreciation for the power of both formal and spontaneous collaboration. […] The significant investment in expanding and enhancing our Athens Global Innovation site will provide not only a comfortable and flexible physical space that inspires collaboration, but also will bring many new tools and technologies to spark the innovation that will ultimately help improve animal and human wellbeing.†[…]

“Through the successful growth and addition of companies like Boehringer Ingelheim, Georgia continues to establish itself as a growing hub for research and innovation within the life sciences industry. […] Boehringer Ingelheim has long been an important part of our life sciences community in Georgia, leveraging innovative connections and resources across the University System of Georgia to perform cutting-edge research into the prevention and treatment of animal diseases. It is always exciting to celebrate growth within an important existing industry, but even more gratifying when the work being done in Georgia could potentially have such a far reaching impact.â€

AREA DEVELOPMENT MAGAZINE

To read the previous Area Development update on Right to Work states, click here.

To read more updates on Right to Work states, click here.